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Abstract
Background: Crack pipe sharing can increase health risks among people who use drugs, yet the reasons for
sharing these pipes have not been well described. Therefore, we sought to identify the prevalence and correlates
of crack pipe sharing among a community-recruited sample of people who use illicit drugs in Vancouver, a setting
where crack pipes are provided at low or no cost.
Findings: Data for this study were derived from two prospective cohorts of people who use drugs: the Vancouver
Injection Drug Users Study (VIDUS) and the AIDS Care Cohort to evaluate Exposure to Survival Services (ACCESS).
Multivariate logistic regression was used to identify factors independently associated with crack pipe sharing.
Among 503 crack users, 238 (47.3%) participants reported having shared a crack pipe in the previous six months.
Having acquired a mouthpiece in the last six months (adjusted odds ratio [AOR] = 1.91; 95% confidence interval
[CI]: 1.31 - 2.79) and difficulty finding new pipes (AOR = 2.19; 95%CI: 1.42 - 3.37) were positively associated with
pipe sharing. Binge drug use (AOR = 1.39; 95%CI: 0.96 - 2.02) was marginally associated with sharing pipes.
Discussion: There was a high prevalence of crack pipe sharing in a setting where crack pipes are distributed at
low or no cost. Difficulty accessing crack pipes was independently and positively associated with this behavior.
These findings suggest that additional efforts are needed to discourage crack pipe sharing as well as increase
access to crack pipes.
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Introduction
Crack cocaine use continues to be associated with var-
ious health-related harms. Injuries such as blisters, sores,
and cuts on the lips and gums are common among peo-
ple who smoke crack [1], and crack use has been asso-
ciated with hepatitis C virus (HCV) and human
immunodeficiency virus (HIV) infection [2,3]. There is
evidence suggesting that injuries to the oral mucosa pro-
mote the transmission of HCV when crack smoking
paraphernalia are shared between individuals with oral
lesions [4]. However, in the case of HIV, the transmission
pathways have not been determined and may reflect ele-
vated syringe sharing or unsafe sex among crack users
[2,5]. Other studies have pointed to crack use as a poten-
tial mode for the transmission of other infectious diseases
including tuberculosis [6,7]. However, increasing access
to crack pipes may reduce the frequency of injecting and
by extension, blood-borne disease transmission among
this population [8].
There is growing support for programs that facilitate
access to sterile and safer crack smoking paraphernalia
[8,9]. However, these programs remain controversial, and
in Canada a number of these programs have been shut-
down in response to concerns expressed by policy makers
and the public [10,11]. Despite these developments and
the high prevalence of crack cocaine use in settings
throughout North America [2,12,13], little is known about
why people who smoke crack continue to engage in risky
behavior such as crack pipe sharing. Further, although
past research has revealed that problems with access to
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sterile syringes can drive syringe sharing in settings where
large needle exchange programs operate [14], little is
known about the relationship between crack pipe access
and crack pipe sharing. Therefore, we sought to investigate
crack pipe sharing and access in Vancouver, Canada, a set-
ting where crack smoking is prevalent and where crack
pipes are provided at no or low cost.
Background
Vancouver has experienced a massive growth in crack use
over the past decade [12]. According to the 2010 Canadian
Alcohol and Drug Use Monitoring Survey, the prevalence
of crack cocaine use in BC (6.9%) is higher than in any
other province [15]. A study in Vancouver demonstrated
that among a sample of drug-using participants, daily
crack use increased from 7.4% in 1996 to 42.6% in 2005.
In the same study, crack use was independently associated
with several characteristics, including sex work involve-
ment and unstable housing [12]. Crack cocaine smoking
has also been associated with the acquisition of HIV infec-
tion among people who inject drugs (IDU) in the city [2].
Locally, crack smoking paraphernalia, including Pyrex
pipes, plastic mouthpieces and wooden push sticks, are
provided through the BC Centre for Disease Control
(BCCDC). A mouthpiece made of clear vinyl tubing is
used as an attachment for crack pipes as a means of redu-
cing risks for blood-borne disease transmission and other
harms [16]. Wooden push sticks are used as an alternative
to plastic syringe plungers, which are often used when
packing a screen into a pipe [17]. Distributing wooden
sticks helps reduce the likelihood that melted plastic is
inhaled and also prevents the misuse and discarding of
syringes [17]. Crack pipes in the form of hollow glass
tubes are available at some harm reduction distribution
sites in Vancouver at no or low cost, but are not univer-
sally available for free throughout the city. Local stores
also sell crack pipes in areas where crack smokers live or
congregate.
Methods
Data for this study were derived from two prospective
cohorts involving people who use drugs: the Vancouver
Injection Drug Users Study (VIDUS) and the AIDS Care
Cohort to evaluate Exposure to Survival Services
(ACCESS). The methods for these studies have been pre-
viously described [18,19]. In brief, beginning in May 1996,
participants were recruited through street outreach and
self-referral in the Greater Vancouver Regional District.
VIDUS eligibility criteria included having injected illicit
drugs at least once in the previous month. ACCESS elig-
ibility criteria included being HIV-positive, and having
used illicit drugs other than cannabinoids in the previous
month. At baseline visit and semi-annually thereafter,
participants complete an interviewer-administered
questionnaire and provide blood samples. The question-
naire elicits information about socio-demographic charac-
teristics, drug use and other behavioral patterns, income-
generation practices, engagement with medical and addic-
tion treatment services, law enforcement encounters, and
other experiences with the criminal justice system. At
each study visit participants were provided with an honor-
aria ($20 CAD). The study has received ethics approval
from the University of British Columbia/Providence
Health Care Research Ethics Board. The present analyses
were restricted to participants who reported smoking
crack cocaine in the last six months, and were seen
between December 2010 and May 2011. We selected the
most recent follow-up period due to recent changes to the
crack pipe distribution program in Vancouver. Specifically,
we wanted to characterize current rates of sharing among
this subpopulation in the wake of these programmatic
changes. The collection of these data is being used to
inform program development for crack users.
For the present analyses, we used univariate and multi-
variate logistic regression, with the outcome being having
reported crack pipe sharing in the last six months. In this
instance, crack pipe sharing referred to either crack pipe
borrowing or lending. Variables considered included: med-
ian age, gender, living in the Downtown Eastside (DTES)
of Vancouver (yes vs. no), frequency of crack use (≥ once
per day vs. < once per day), having acquired a mouthpiece
(yes vs. no), difficulty accessing crack pipes (yes/sometimes
vs. no), smoking crack in public (always/usually vs. some-
times/occasionally/never), and binge use of non-injection
drugs (yes vs. no). All behavioral variables refer to beha-
viors in the past six months. The variable “having acquired
a mouthpiece” referred to obtaining a sterile mouthpiece
from sites distributing crack pipe supplies. Additionally,
the variable “difficulty accessing pipes” referred to whether
participants found it difficult to obtain new crack pipes
when they needed them. “Binge use of non-injection
drugs” referred to whether the participant used non-injec-
tion drugs more than usual. To examine bivariate associa-
tions, we used the Pearson c2 test. Fisher’s exact test was
used when one or more cells contained values less than or
equal to five. We then built a multivariate logistic regres-
sion model to identify independent predictors of crack
pipe sharing by including all variables that were associated
with the outcome at the p ≤ 0.10 level in bivariate analyses.
All p-values were two-sided. As a subanalysis, we asked
participants to specify where they acquired their crack
pipes.
Results
In total, 503 drug users reporting crack cocaine smoking
in the past six months participated in this study, includ-
ing 181 (36.0%) females. These participants represented
61.1% of the total number of participants who were
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recruited into both VIDUS and ACCESS cohorts for this
study period. The median age of participants was 46
years (range = 23 - 72 years). In total, 238 (47.3%)
reported having shared a crack pipe in the last six
months. As well, 63.6% were active injection drug users
and 60.6% reported having been in alcohol or drug treat-
ment in the past six months. As indicated in Table 1, fac-
tors significantly and positively associated with crack
pipe sharing included having acquired a mouthpiece, dif-
ficulty accessing crack pipes, and binge use of non-injec-
tion drugs. Additionally, age was negatively associated
with pipe sharing (all p < 0.10).
As indicated in Table 2, in multivariate analyses, factors
that remained positively associated with crack pipe shar-
ing included: having acquired a mouthpiece and difficulty
accessing crack pipes (p < 0.05). Participants reported
access to crack pipes through a variety of sources, includ-
ing: street (new) (39.4%), corner store (29.8%), a drug
user-run organization (25.6%), and local health programs
(8.2%). As well, a number of participants (9.9%) reported
acquiring used pipes from the street.
Discussion
In the present analyses, we found a high rate of crack
pipe sharing among illicit drug users in Vancouver, with
just under 50% of participants reporting crack pipe shar-
ing in the previous six months. Those participants who
reported sharing crack pipes were more likely to report
having recently acquired a mouthpiece and to have
experienced difficulty accessing pipes.
Our findings are consistent with previous studies
reporting high rates of crack pipe sharing among people
who smoke crack [8]. Although there is limited evidence
concerning the impact of programs that target crack
smokers, a study in Ottawa, Canada reported positive
outcomes from distributing crack-smoking paraphernalia,
including a decline in the frequency of pipe sharing [8].
Given the health risks associated with pipe sharing and
our finding that difficulty accessing pipes was associated
with sharing, increasing access to crack pipes has poten-
tial to reduce the transmission of infectious diseases as
well as injuries to the oral cavity via use of makeshift
devices [4,6].
Table 1 Bivariate analyses of factors associated with crack pipe sharing among people who smoke crack cocaine (n = 503)
Shared a crack pipe in the last six months n (%)
Characteristic Yes
238 (47.3)
No
265 (52.7)
Odds Ratio (95% CI) p - value
Age
≥ 46 years old 116 (43.8) 149 (56.2) 0.74 (0.52 - 1.05) 0.09
< 46 years old 122 (51.3) 116 (48.7)
Gender
Female 84 (46.4) 97 (53.6) 0.94 (0.66 - 1.36) 0.76
Male 154 (47.8) 168 (52.2)
Living in DTES
Yes 157 (45.4) 189 (54.6) 0.78 (0.53 - 1.14) 0.20
No 81 (51.6) 76 (48.4)
Frequency of crack use*
≥ once per day 99 (51.6) 93 (48.4) 1.32 (0.92 - 1.89) 0.13
< once per day 139 (44.7) 172 (55.3)
Acquired mouthpiece*
Yes 162 (54.9) 133 (45.1) 2.12 (1.47 - 3.04) < 0.01
No 76 (36.5) 132 (63.5)
Difficulty accessing pipes
Yes/Sometimes 78 (63.4) 45 (36.6) 2.38 (1.57 - 3.63) < 0.01
No 160 (42.1) 220 (57.9)
Smoke in public*
Always/Usually 53 (52.0) 49 (48.0) 1.26 (0.82 - 1.95) 0.29
Sometimes/Occasionally/Never 185 (46.1) 216 (53.9)
Binge drug use (non-injection)*1
Yes 127 (53.8) 109 (46.2) 1.65 (1.15 - 2.36) < 0.01
No 106 (41.4) 150 (58.6)
DTES: Downtown Eastside of Vancouver
CI: confidence interval
*Activities/events in the last six months
1Note that counts for binge drug use do not add up to n = 503 due to 11 missing responses (n = 492).
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Recent efforts have been made by BCCDC to distri-
bute mouthpieces province-wide. Mouthpiece distribu-
tion provides a point of engagement for crack smokers
who may not inject since many may not have been con-
nected with harm reduction services otherwise [16]. In
the event where crack pipes are unavailable, and sharing
a pipe becomes inevitable, mouthpieces can alleviate the
risk of injuries and infections associated with pipe shar-
ing. Consistently, our findings showed a positive associa-
tion between mouthpiece acquisition and sharing crack
pipes, indicating that many people who smoke crack are
practicing safer smoking methods. However, it is unclear
whether individuals are using their own mouthpiece
when sharing pipes. Given the lack of evidence describ-
ing the negative health consequences from sharing a
mouthpiece, future research should focus on examining
the different health risks between individuals who share
and do not share mouthpieces.
This study has limitations. First, because of the cross-
sectional design, determining a temporal relationship
between exposure and outcome is not possible. Second,
both VIDUS and ACCESS cohorts are community-
recruited non-randomized samples of IDU and HIV-posi-
tive drug users and therefore our findings may not be gen-
eralizable to all crack cocaine users in local or other
settings. Third, from this study, it is not clear whether the
participants are using their own mouthpiece, sharing a
mouthpiece, or not using a mouthpiece at all when they
are sharing crack pipes. Lastly, the data collected were
self-reported and may be subject to reporting biases.
In summary, we found that crack pipe sharing is com-
mon among people who smoke crack in Vancouver. Diffi-
culty accessing pipes and having acquired a mouthpiece
were positively associated with crack pipe sharing.
Although many cities worldwide, including Vancouver,
have succeeded in providing harm reduction paraphernalia
for IDU, similar services for people who smoke crack are
not as readily available [20]. Our findings suggest that
additional crack pipe distribution efforts are needed to
address the risks and harms associated with crack use.
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Table 2 Multivariate logistic regression analyses of factors associated with crack pipe sharing among people who
smoke crack cocaine (n = 503)1
Variable Adjusted Odds Ratio (AOR) 95% CI p - value
Age
(≥ 46 years vs. < 46 years) 0.80 (0.56 - 1.17) 0.25
Acquired mouthpiece*
(Yes vs. No) 1.91 (1.31 - 2.79) < 0.01
Difficulty accessing pipes
(Yes/Sometimes vs. No) 2.19 (1.42 - 3.37) < 0.01
Binge drug use (non-injection)*
(Yes vs. No) 1.39 (0.96 - 2.02) 0.08
CI: confidence interval
*Activities/events in the last six months
1Χ2 (Likelihood Ratio Test) = 35.68; p-value = < 0.01; R2 = 0.07
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